Document is current
Any future updates will be listed below
-
Authors
Jones, Gieira S.
Hoadley, Katherine A.
Olsson, Linnea T.
Hamilton, Alina M.
Bhattacharya, Arjun
Kirk, Erin L.
Tipaldos, Heather J.
Fleming, Jodie M.
Love, Michael I.
Nichols, Hazel B.
Olshan, Andrew F.
Troester, Melissa A.
-
Funding
Funding for this research was provided by:
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (T32CA057726)
Susan G. Komen (OGUNC1202)
National Cancer Institute (P01CA151135, P50CA58223)
National Institute of Environmental Health Sciences (T32ES007018)
- License Information
-
More Information
Article History
Received: 6 May 2021
Accepted: 20 July 2021
First Online: 3 August 2021
Declarations
:
: The study was approved by the University of North Carolina at Chapel Hill Office of Human Ethics and Institutional Review Board. The Carolina Breast Cancer Study obtained informed consent from all participants.
: This manuscript has been approved by all co-authors.
: The University of North Carolina is an interest owner in University Genomics, the patent holder of the PAM50 assay.
